あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/18 | 1,155 | 1,168 | 1,151 | 1,165 | +16 | +1.4% | 27,800 |
| 2022/11/17 | 1,141 | 1,153 | 1,139 | 1,149 | +4 | +0.3% | 20,600 |
| 2022/11/16 | 1,137 | 1,154 | 1,133 | 1,145 | +8 | +0.7% | 22,200 |
| 2022/11/15 | 1,114 | 1,148 | 1,114 | 1,137 | +23 | +2.1% | 32,300 |
| 2022/11/14 | 1,123 | 1,124 | 1,114 | 1,114 | -7 | -0.6% | 34,900 |
| 2022/11/11 | 1,144 | 1,144 | 1,112 | 1,121 | -2 | -0.2% | 58,900 |
| 2022/11/10 | 1,145 | 1,145 | 1,121 | 1,123 | -27 | -2.3% | 59,300 |
| 2022/11/09 | 1,188 | 1,188 | 1,146 | 1,150 | -33 | -2.8% | 52,900 |
| 2022/11/08 | 1,159 | 1,187 | 1,155 | 1,183 | +36 | +3.1% | 104,200 |
| 2022/11/07 | 1,150 | 1,163 | 1,143 | 1,147 | +9 | +0.8% | 29,900 |
| 2022/11/04 | 1,150 | 1,156 | 1,133 | 1,138 | -14 | -1.2% | 54,500 |
| 2022/11/02 | 1,157 | 1,162 | 1,148 | 1,152 | -10 | -0.9% | 22,000 |
| 2022/11/01 | 1,175 | 1,183 | 1,156 | 1,162 | -10 | -0.9% | 34,200 |
| 2022/10/31 | 1,150 | 1,177 | 1,149 | 1,172 | +37 | +3.3% | 44,700 |
| 2022/10/28 | 1,130 | 1,152 | 1,125 | 1,135 | -6 | -0.5% | 124,500 |
| 2022/10/27 | 1,149 | 1,151 | 1,138 | 1,141 | -13 | -1.1% | 24,700 |
| 2022/10/26 | 1,139 | 1,154 | 1,134 | 1,154 | +18 | +1.6% | 20,100 |
| 2022/10/25 | 1,141 | 1,153 | 1,130 | 1,136 | -3 | -0.3% | 35,700 |
| 2022/10/24 | 1,145 | 1,151 | 1,139 | 1,139 | +1 | +0.1% | 24,700 |
| 2022/10/21 | 1,137 | 1,147 | 1,135 | 1,138 | -8 | -0.7% | 27,700 |
| 2022/10/20 | 1,147 | 1,151 | 1,141 | 1,146 | -21 | -1.8% | 21,800 |
| 2022/10/19 | 1,167 | 1,169 | 1,152 | 1,167 | ±0 | ±0% | 28,300 |
| 2022/10/18 | 1,150 | 1,172 | 1,145 | 1,167 | +11 | +1% | 47,100 |
| 2022/10/17 | 1,168 | 1,168 | 1,154 | 1,156 | -23 | -2% | 25,600 |
| 2022/10/14 | 1,174 | 1,189 | 1,165 | 1,179 | +32 | +2.8% | 44,100 |
| 2022/10/13 | 1,145 | 1,152 | 1,139 | 1,147 | +2 | +0.2% | 36,300 |
| 2022/10/12 | 1,140 | 1,155 | 1,132 | 1,145 | ±0 | ±0% | 33,300 |
| 2022/10/11 | 1,150 | 1,168 | 1,142 | 1,145 | -32 | -2.7% | 37,000 |
| 2022/10/07 | 1,150 | 1,185 | 1,150 | 1,177 | +10 | +0.9% | 36,100 |
| 2022/10/06 | 1,148 | 1,174 | 1,148 | 1,167 | +20 | +1.7% | 36,100 |
| 2022/10/05 | 1,169 | 1,169 | 1,147 | 1,147 | -11 | -0.9% | 31,800 |
| 2022/10/04 | 1,144 | 1,160 | 1,144 | 1,158 | +37 | +3.3% | 43,300 |
| 2022/10/03 | 1,116 | 1,125 | 1,103 | 1,121 | +8 | +0.7% | 26,900 |
| 2022/09/30 | 1,131 | 1,145 | 1,110 | 1,113 | -27 | -2.4% | 37,300 |
| 2022/09/29 | 1,125 | 1,146 | 1,125 | 1,140 | +30 | +2.7% | 81,300 |
| 2022/09/28 | 1,095 | 1,110 | 1,078 | 1,110 | +2 | +0.2% | 90,900 |
| 2022/09/27 | 1,094 | 1,121 | 1,094 | 1,108 | +14 | +1.3% | 37,800 |
| 2022/09/26 | 1,100 | 1,115 | 1,084 | 1,094 | -7 | -0.6% | 56,200 |
| 2022/09/22 | 1,080 | 1,104 | 1,080 | 1,101 | +11 | +1% | 32,600 |
| 2022/09/21 | 1,112 | 1,112 | 1,086 | 1,090 | -35 | -3.1% | 53,500 |
| 2022/09/20 | 1,121 | 1,137 | 1,121 | 1,125 | +4 | +0.4% | 25,300 |
| 2022/09/16 | 1,140 | 1,141 | 1,118 | 1,121 | -24 | -2.1% | 36,700 |
| 2022/09/15 | 1,166 | 1,166 | 1,141 | 1,145 | -12 | -1% | 24,800 |
| 2022/09/14 | 1,153 | 1,182 | 1,151 | 1,157 | -42 | -3.5% | 45,400 |
| 2022/09/13 | 1,192 | 1,206 | 1,178 | 1,199 | +10 | +0.8% | 41,100 |
| 2022/09/12 | 1,188 | 1,193 | 1,174 | 1,189 | +10 | +0.8% | 34,800 |
| 2022/09/09 | 1,160 | 1,190 | 1,154 | 1,179 | +17 | +1.5% | 71,600 |
| 2022/09/08 | 1,138 | 1,166 | 1,138 | 1,162 | +31 | +2.7% | 50,400 |
| 2022/09/07 | 1,133 | 1,139 | 1,117 | 1,131 | -16 | -1.4% | 42,100 |
| 2022/09/06 | 1,147 | 1,162 | 1,139 | 1,147 | -4 | -0.3% | 36,100 |
601～
650
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 49,400円 | -23.0% | - | 4.05% | - | 1.06倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ハートシード | 252,300円 | +174.2% | - | 0.00% | - | 8.59倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
